Sabine C. Zimmermann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sabine C. Zimmermann has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Cindy Thamrin
Woolcock Institute of Medical Research, The University of Sydney, Sydney, New South Wales, Australia
6 shared publications - David Geoffrey Chapman
School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia
4 shared publications - Katrina O. Tonga
Airway Physiology and Imaging Group, Woolcock Institute of Medical Research, The University of Sydney, Sydney, Australia
4 shared publications Amy Bertolin
Airway Physiology and Imaging Group, Woolcock Institute of Medical Research, The University of Sydney, Glebe, NSW, Australia
3 shared publicationsGregory G. King
Airway Physiology & Imaging Group and Woolcock Emphysema Centre, Woolcock Institute of Medical Research, The University of Sydney, Glebe, NSW, Australia
3 shared publications- Claude S. Farah
Department of Thoracic Medicine Concord Hospital Concord Australia
2 shared publications
Latest Publications
- 9 March 2023
- Published by Georg Thieme Verlag KG in Pneumologie
- Vol. 77 (S 01) , S100-S101
Heilung einer pulmonalen Hypertonie durch autologe Stammzell-Transplantation
Hintergrund Die PAH ist eine chronische, lebensbedrohliche Erkrankung, deren Prognose sich aufgrund verbesserter Behandlungsmöglichkeiten zwar verbessert hat, aktuell jedoch höchstens durch eine Lungentransplantation heilbar ist. Es gibt nur sehr wenige Beschreibungen von Patienten mit pulmonaler Hypertonie, die durch andere Therapien geheilt wurden. Fallbeschreibung Ein 61j. Patient wurde in unser PH-Zentrum überwiesen mit Erstdiagnose einer schweren IPAH mit positiver Vasoresponse. Therapieversuche mit CCB wurden aufgrund von Nebenwirkungen abgebrochen. Daher erhielt der Patient eine Therapie mit Sildenafil, worunter sich Belastbarkeit und Hämodynamik verbesserten. Er präsentierte im Verlauf atypische Symptome mit Beinschwäche, ausgeprägter Asthenie, Nachtschweiß und rezidivierenden Pleuraergüssen. Ursächlich zeigte sich eine beinbetonte axonal demyelenisierende Polyneuropathie, primäre NNR-Insuffizienz und Hypogonadismus, transsudative Ergüsse, Splenomegalie und Lymphadenopathie, welche zur Diagnose eines POEMS Syndroms (Polyneuropathie, Organomegaly, Endokrinopathie, MGUS, Skin Lesions, Pulmonale Hypertonie) und schließlich eines idiopathischen multizentrischen M. Castleman vom hyalin-vaskulären Typ führten. Diese seltene hämatologische Erkrankung geht mit lymphatischer Proliferation und starker Produktion von IL-6 und VEGF einher. Der VEGF-Spiegel im Serum des Patienten war initial massiv erhöht (>7000pg/ml). Es erfolgte eine Chemotherapie mit 6xVCD, dann Hochdosis-CTx+autologe Stammzell-Transplantation (ASCT), worunter sich der VEGF-Spiegel normalisierte und alle Symptome rückläufig waren. Hiernach zeigte sich eine normalisierte Hämodynamik, welche>1 Jahr nach ASCT und nach Absetzen von Sildenafil erhalten blieb. Fazit Auch wenn das POEMS Syndrom eine seltene Ursache einer PH ist, verdeutlicht dieser Fall eine potenzielle Reversibilität bestimmter pathogenetischer Mechanismen sowie die Bedeutung des VEGF-Signaling, welches auch bei IPAH eine Rolle spielt. Article published online: 09 March 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany
- 9 March 2023
- Published by Georg Thieme Verlag KG in Pneumologie
- Vol. 77 (S 01) , S100-S101
Heilung einer pulmonalen Hypertonie durch autologe Stammzell-Transplantation
Hintergrund Die PAH ist eine chronische, lebensbedrohliche Erkrankung, deren Prognose sich aufgrund verbesserter Behandlungsmöglichkeiten zwar verbessert hat, aktuell jedoch höchstens durch eine Lungentransplantation heilbar ist. Es gibt nur sehr wenige Beschreibungen von Patienten mit pulmonaler Hypertonie, die durch andere Therapien geheilt wurden. Fallbeschreibung Ein 61j. Patient wurde in unser PH-Zentrum überwiesen mit Erstdiagnose einer schweren IPAH mit positiver Vasoresponse. Therapieversuche mit CCB wurden aufgrund von Nebenwirkungen abgebrochen. Daher erhielt der Patient eine Therapie mit Sildenafil, worunter sich Belastbarkeit und Hämodynamik verbesserten. Er präsentierte im Verlauf atypische Symptome mit Beinschwäche, ausgeprägter Asthenie, Nachtschweiß und rezidivierenden Pleuraergüssen. Ursächlich zeigte sich eine beinbetonte axonal demyelenisierende Polyneuropathie, primäre NNR-Insuffizienz und Hypogonadismus, transsudative Ergüsse, Splenomegalie und Lymphadenopathie, welche zur Diagnose eines POEMS Syndroms (Polyneuropathie, Organomegaly, Endokrinopathie, MGUS, Skin Lesions, Pulmonale Hypertonie) und schließlich eines idiopathischen multizentrischen M. Castleman vom hyalin-vaskulären Typ führten. Diese seltene hämatologische Erkrankung geht mit lymphatischer Proliferation und starker Produktion von IL-6 und VEGF einher. Der VEGF-Spiegel im Serum des Patienten war initial massiv erhöht (>7000pg/ml). Es erfolgte eine Chemotherapie mit 6xVCD, dann Hochdosis-CTx+autologe Stammzell-Transplantation (ASCT), worunter sich der VEGF-Spiegel normalisierte und alle Symptome rückläufig waren. Hiernach zeigte sich eine normalisierte Hämodynamik, welche>1 Jahr nach ASCT und nach Absetzen von Sildenafil erhalten blieb. Fazit Auch wenn das POEMS Syndrom eine seltene Ursache einer PH ist, verdeutlicht dieser Fall eine potenzielle Reversibilität bestimmter pathogenetischer Mechanismen sowie die Bedeutung des VEGF-Signaling, welches auch bei IPAH eine Rolle spielt. Article published online: 09 March 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 29 October 2020
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 7 (1)
Higher body mass index is associated with increased lung stiffness and less airway obstruction in individuals with asthma and fixed airflow obstruction
Persistent or fixed airflow obstruction (FAO) is prevalent in up to 60% of patients with severe asthma[1] and is associated with older age, more rapid decline in lung function and increased symptoms[1-3]. The underlying mechanisms of FAO in asthma are unknown, but growing evidence suggest that parenchymal changes resulting in loss of elastic recoil and decreased lung stiffness (i.e. increased lung compliance) contribute to FAO[2, 4]. In a recent study of older asthma patients with FAO, decreased lung stiffness was the sole predictor of more severe airflow obstruction, as measured by reduced FEV 1 /FVC ratio[2].
- 29 October 2020
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 7 (1)
Open AccessHigher body mass index is associated with increased lung stiffness and less airway obstruction in individuals with asthma and fixed airflow obstruction
Persistent or fixed airflow obstruction (FAO) is prevalent in up to 60% of patients with severe asthma[1] and is associated with older age, more rapid decline in lung function and increased symptoms[1-3]. The underlying mechanisms of FAO in asthma are unknown, but growing evidence suggest that parenchymal changes resulting in loss of elastic recoil and decreased lung stiffness (i.e. increased lung compliance) contribute to FAO[2, 4]. In a recent study of older asthma patients with FAO, decreased lung stiffness was the sole predictor of more severe airflow obstruction, as measured by reduced FEV 1 /FVC ratio[2].
- 19 May 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (3) , 1901739
Day-to-day variability of forced oscillatory mechanics for early detection of acute exacerbations in COPD
Background: Telemonitoring trials for early detection of acute exacerbations of chronic obstructive pulmonary disease (AECOPD) have provided mixed results. Day-to-day variations in lung function measured by the forced oscillation technique (FOT) may yield greater insight. We evaluated the clinical utility of home telemonitoring of variability in FOT measures in terms of 1) the relationship with symptoms and quality of life (QoL); and 2) the timing of variability of FOT measures and symptom changes prior to AECOPD.Methods: Daily FOT parameters at 5 Hz (resistance (R) and reactance (X); Resmon Pro Diary, Restech Srl, Milan, Italy), daily symptoms (COPD Assessment Test (CAT)) and 4-weekly QoL data (St George's Respiratory Questionnaire (SGRQ)) were recorded over 8–9 months from chronic obstructive pulmonary disease (COPD) patients. Variability of R and X was calculated as the standard deviation (sd) over 7-day running windows and we also examined the effect of varying window size. The relationship of FOTversusCAT and SGRQ was assessed using linear mixed modelling, daily changes in FOT variability and CAT prior to AECOPD using one-way repeated measures ANOVA.Results: Fifteen participants with a mean±sdage of 69±10 years and a % predicted forced expiratory volume in 1 s (FEV1) of 39±10% had a median (interquartile range (IQR)) adherence of 95.4% (79.0–98.8%). Variability of the inspiratory component of X (indicated by the standard deviation of inspiratory reactance (SDXinsp)) related to CAT and weakly to SGRQ (fixed effect estimates 1.57, 95% CI 0.65–2.49 (p=0.001) and 4.41, 95% CI −0.06 to 8.89 (p=0.05), respectively). SDXinspchanged significantly on the same day as CAT (1 day before AECOPD, both p=0.02) and earlier when using shorter running windows (3 days before AECOPD, p=0.01; accuracy=0.72 for 5-day windows).Conclusions: SDXinspfrom FOT telemonitoring reflects COPD symptoms and may be a sensitive biomarker for early detection of AECOPD.
- 19 May 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (3) , 1901739
Day-to-day variability of forced oscillatory mechanics for early detection of acute exacerbations in COPD
Background: Telemonitoring trials for early detection of acute exacerbations of chronic obstructive pulmonary disease (AECOPD) have provided mixed results. Day-to-day variations in lung function measured by the forced oscillation technique (FOT) may yield greater insight. We evaluated the clinical utility of home telemonitoring of variability in FOT measures in terms of 1) the relationship with symptoms and quality of life (QoL); and 2) the timing of variability of FOT measures and symptom changes prior to AECOPD.Methods: Daily FOT parameters at 5 Hz (resistance (R) and reactance (X); Resmon Pro Diary, Restech Srl, Milan, Italy), daily symptoms (COPD Assessment Test (CAT)) and 4-weekly QoL data (St George's Respiratory Questionnaire (SGRQ)) were recorded over 8–9 months from chronic obstructive pulmonary disease (COPD) patients. Variability of R and X was calculated as the standard deviation (sd) over 7-day running windows and we also examined the effect of varying window size. The relationship of FOTversusCAT and SGRQ was assessed using linear mixed modelling, daily changes in FOT variability and CAT prior to AECOPD using one-way repeated measures ANOVA.Results: Fifteen participants with a mean±sdage of 69±10 years and a % predicted forced expiratory volume in 1 s (FEV1) of 39±10% had a median (interquartile range (IQR)) adherence of 95.4% (79.0–98.8%). Variability of the inspiratory component of X (indicated by the standard deviation of inspiratory reactance (SDXinsp)) related to CAT and weakly to SGRQ (fixed effect estimates 1.57, 95% CI 0.65–2.49 (p=0.001) and 4.41, 95% CI −0.06 to 8.89 (p=0.05), respectively). SDXinspchanged significantly on the same day as CAT (1 day before AECOPD, both p=0.02) and earlier when using shorter running windows (3 days before AECOPD, p=0.01; accuracy=0.72 for 5-day windows).Conclusions: SDXinspfrom FOT telemonitoring reflects COPD symptoms and may be a sensitive biomarker for early detection of AECOPD.
- Open Access
- 1 January 2020
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 15, 157-166
Relationships Between Forced Oscillatory Impedance and 6-minute Walk Distance After Pulmonary Rehabilitation in COPD
Rationale: Pulmonary rehabilitation for chronic obstructive pulmonary disease (COPD) reduces dyspnoea and improves exercise capacity and quality of life. The improvement in exercise capacity is variable and unpredictable, however. Respiratory system impedance obtained by forced oscillation technique (FOT) as a measure of ventilatory impairment in COPD may relate to improvement in exercise capacity with pulmonary rehabilitation. We aimed to determine if baseline FOT parameters relate to changes in exercise capacity following pulmonary rehabilitation. Methods: At the start of rehabilitation, 15 COPD subjects (mean(SD) 75.2(6.1) years, FEV1 z-score − 2.61(0.84)) had measurements by FOT, spirometry, plethysmographic lung volumes and 6-minute walk distance (6MWD). Respiratory system resistance (Rrs) and reactance (Xrs) parameters as the mean over all breaths (Rmean, Xmean), during inspiration only (Rinsp, Xinsp), and expiratory flow limitation (DeltaXrs = Xinsp−Xexp), were calculated. FOT and 6MWD measurements were repeated at completion of rehabilitation and 3 months after completion. Results: At baseline, Xrs measures were unrelated to 6MWD. Xinsp improved significantly with rehabilitation (from mean(SD) − 2.35(1.02) to − 2.04(0.85) cmH 2O.s.L− 1, p=0.008), while other FOT parameters did not. No FOT parameters related to the change in 6MWD at program completion. Baseline Xmean, DeltaXrs, and FVC z-score correlated with the change in 6MWD between completion and 3 months after completion of rehabilitation (rs=0.62, p=0.03; rs=− 0.65, p=0.02; and rs=0.62, p=0.03, respectively); with worse ventilatory impairment predicting loss of 6MWD. There were no relationships between Rrs parameters, FEV1 or FEV1/FVC z-scores and changes in 6MWD. Conclusion: Baseline reactance parameters may be helpful in predicting those patients with COPD at most risk of loss of exercise capacity following completion of pulmonary rehabilitation.
- 1 January 2020
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 15, 157-166
Open AccessRelationships Between Forced Oscillatory Impedance and 6-minute Walk Distance After Pulmonary Rehabilitation in COPD
Rationale: Pulmonary rehabilitation for chronic obstructive pulmonary disease (COPD) reduces dyspnoea and improves exercise capacity and quality of life. The improvement in exercise capacity is variable and unpredictable, however. Respiratory system impedance obtained by forced oscillation technique (FOT) as a measure of ventilatory impairment in COPD may relate to improvement in exercise capacity with pulmonary rehabilitation. We aimed to determine if baseline FOT parameters relate to changes in exercise capacity following pulmonary rehabilitation. Methods: At the start of rehabilitation, 15 COPD subjects (mean(SD) 75.2(6.1) years, FEV1 z-score − 2.61(0.84)) had measurements by FOT, spirometry, plethysmographic lung volumes and 6-minute walk distance (6MWD). Respiratory system resistance (Rrs) and reactance (Xrs) parameters as the mean over all breaths (Rmean, Xmean), during inspiration only (Rinsp, Xinsp), and expiratory flow limitation (DeltaXrs = Xinsp−Xexp), were calculated. FOT and 6MWD measurements were repeated at completion of rehabilitation and 3 months after completion. Results: At baseline, Xrs measures were unrelated to 6MWD. Xinsp improved significantly with rehabilitation (from mean(SD) − 2.35(1.02) to − 2.04(0.85) cmH 2O.s.L− 1, p=0.008), while other FOT parameters did not. No FOT parameters related to the change in 6MWD at program completion. Baseline Xmean, DeltaXrs, and FVC z-score correlated with the change in 6MWD between completion and 3 months after completion of rehabilitation (rs=0.62, p=0.03; rs=− 0.65, p=0.02; and rs=0.62, p=0.03, respectively); with worse ventilatory impairment predicting loss of 6MWD. There were no relationships between Rrs parameters, FEV1 or FEV1/FVC z-scores and changes in 6MWD. Conclusion: Baseline reactance parameters may be helpful in predicting those patients with COPD at most risk of loss of exercise capacity following completion of pulmonary rehabilitation.
- 1 November 2019
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 127 (5) , 1441-1452
Time-based pulmonary features from electrical impedance tomography demonstrate ventilation heterogeneity in chronic obstructive pulmonary disease
Pulmonary electrical impedance tomography (EIT) is a functional imaging technique that allows real-time monitoring of ventilation distribution. Ventilation heterogeneity (VH) is a characteristic feature of chronic obstructive pulmonary disease (COPD) and has previously been quantified using features derived from tidal variations in the amplitude of the EIT signal. However, VH may be better described by time-based metrics, the measurement of which is made possible by the high temporal resolution of EIT. We aimed 1) to quantify VH using novel time-based EIT metrics and 2) to determine the physiological relevance of these metrics by exploring their relationships with complex lung mechanics measured by the forced oscillation technique (FOT). We performed FOT, spirometry, and tidal-breathing EIT measurements in 11 healthy controls and 9 volunteers with COPD. Through offline signal processing, we derived 3 features from the impedance-time ( Z- t) curve for each image pixel: 1) tE, mean expiratory time; 2) PHASE, mean time difference between pixel and global Z- t curves; and 3) AMP, mean amplitude of Z- t curve tidal variation. Distribution was quantified by the coefficient of variation (CV) and the heterogeneity index (HI). Both CV and HI of the tE and PHASE features were significantly increased in COPD compared with controls, and both related to spirometry and FOT resistance and reactance measurements. In contrast, distribution of the AMP feature showed no relationships with lung mechanics. These novel time-based EIT metrics of VH reflect complex lung mechanics in COPD and have the potential to allow real-time visualization of pulmonary physiology in spontaneously breathing subjects. NEW & NOTEWORTHY Pulmonary electrical impedance tomography (EIT) is a real-time imaging technique capable of monitoring ventilation with exquisite temporal resolution. We report novel, time-based EIT measurements that not only demonstrate ventilation heterogeneity in chronic obstructive pulmonary disease (COPD), but also reflect oscillatory lung mechanics. These EIT measurements are noninvasive, radiation-free, easy to obtain, and provide real-time visualization of the complex pathophysiology of COPD.
- 1 November 2019
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 127 (5) , 1441-1452
Time-based pulmonary features from electrical impedance tomography demonstrate ventilation heterogeneity in chronic obstructive pulmonary disease
Pulmonary electrical impedance tomography (EIT) is a functional imaging technique that allows real-time monitoring of ventilation distribution. Ventilation heterogeneity (VH) is a characteristic feature of chronic obstructive pulmonary disease (COPD) and has previously been quantified using features derived from tidal variations in the amplitude of the EIT signal. However, VH may be better described by time-based metrics, the measurement of which is made possible by the high temporal resolution of EIT. We aimed 1) to quantify VH using novel time-based EIT metrics and 2) to determine the physiological relevance of these metrics by exploring their relationships with complex lung mechanics measured by the forced oscillation technique (FOT). We performed FOT, spirometry, and tidal-breathing EIT measurements in 11 healthy controls and 9 volunteers with COPD. Through offline signal processing, we derived 3 features from the impedance-time ( Z- t) curve for each image pixel: 1) tE, mean expiratory time; 2) PHASE, mean time difference between pixel and global Z- t curves; and 3) AMP, mean amplitude of Z- t curve tidal variation. Distribution was quantified by the coefficient of variation (CV) and the heterogeneity index (HI). Both CV and HI of the tE and PHASE features were significantly increased in COPD compared with controls, and both related to spirometry and FOT resistance and reactance measurements. In contrast, distribution of the AMP feature showed no relationships with lung mechanics. These novel time-based EIT metrics of VH reflect complex lung mechanics in COPD and have the potential to allow real-time visualization of pulmonary physiology in spontaneously breathing subjects. NEW & NOTEWORTHY Pulmonary electrical impedance tomography (EIT) is a real-time imaging technique capable of monitoring ventilation with exquisite temporal resolution. We report novel, time-based EIT measurements that not only demonstrate ventilation heterogeneity in chronic obstructive pulmonary disease (COPD), but also reflect oscillatory lung mechanics. These EIT measurements are noninvasive, radiation-free, easy to obtain, and provide real-time visualization of the complex pathophysiology of COPD.
- 3 September 2019
- Published by Wiley in Respirology
- Vol. 25 (6) , 613-619
Reduced lung elastic recoil and fixed airflow obstruction in asthma
Background and objective: Fixed airflow obstruction (FAO) in asthma occurs despite optimal inhaled treatment and no smoking history, and remains a significant problem, particularly with increasing age and duration of asthma. Increased lung compliance and loss of lung elastic recoil has been observed in older people with asthma, but their link to FAO has not been established. We determined the relationship between abnormal lung elasticity and airflow obstruction in asthma.Methods: Non‐smoking asthmatic subjects aged >40 years, treated with 2 months of high‐dose inhaled corticosteroid/long‐acting beta‐agonist (ICS/LABA), had FAO measured by spirometry, and respiratory system resistance at 5 Hz (Rrs5) and respiratory system reactance at 5 Hz (Xrs5) measured by forced oscillation technique. Lung compliance (K) and elastic recoil (B/A) were calculated from pressure–volume curves measured by an oesophageal balloon. Linear correlations between K and B/A, and forced expiratory volume in 1 s/forced vital capacity (FEV1/FVC), Rrs5 and Xrs5 were assessed.Results: Eighteen subjects (11 males; mean ± SD age: 64 ± 8 years, asthma duration: 39 ± 22 years) had moderate FAO measured by spirometry ((mean ± SD z‐score) post‐bronchodilator FEV1: −2.2 ± 0.5, FVC: −0.7 ± 1.0, FEV1/FVC: −2.6 ± 0.7) and by increased Rrs5 (median (IQR) z‐score) 2.7 (1.9 to 3.2) and decreased Xrs5: −4.1(−2.4 to −7.3). Lung compliance (K) was increased in 9 of 18 subjects and lung elastic recoil (B/A) reduced in 5 of 18 subjects. FEV1/FVC correlated negatively with K (rs = −0.60, P = 0.008) and Rrs5 correlated negatively with B/A (rs = −0.52, P = 0.026), independent of age. Xrs5 did not correlate with lung elasticity indices.Conclusion: Increased lung compliance and loss of elastic recoil relate to airflow obstruction in older non‐smoking asthmatic subjects, independent of ageing. Thus, structural lung tissue changes may contribute to persistent, steroid‐resistant airflow obstruction.Clinical trial registration: ACTRN126150000985583 at anzctr.org.au (UTN: U1111‐1156‐2795)
- 3 September 2019
- Published by Wiley in Respirology
- Vol. 25 (6) , 613-619
Reduced lung elastic recoil and fixed airflow obstruction in asthma
Background and objective: Fixed airflow obstruction (FAO) in asthma occurs despite optimal inhaled treatment and no smoking history, and remains a significant problem, particularly with increasing age and duration of asthma. Increased lung compliance and loss of lung elastic recoil has been observed in older people with asthma, but their link to FAO has not been established. We determined the relationship between abnormal lung elasticity and airflow obstruction in asthma.Methods: Non‐smoking asthmatic subjects aged >40 years, treated with 2 months of high‐dose inhaled corticosteroid/long‐acting beta‐agonist (ICS/LABA), had FAO measured by spirometry, and respiratory system resistance at 5 Hz (Rrs5) and respiratory system reactance at 5 Hz (Xrs5) measured by forced oscillation technique. Lung compliance (K) and elastic recoil (B/A) were calculated from pressure–volume curves measured by an oesophageal balloon. Linear correlations between K and B/A, and forced expiratory volume in 1 s/forced vital capacity (FEV1/FVC), Rrs5 and Xrs5 were assessed.Results: Eighteen subjects (11 males; mean ± SD age: 64 ± 8 years, asthma duration: 39 ± 22 years) had moderate FAO measured by spirometry ((mean ± SD z‐score) post‐bronchodilator FEV1: −2.2 ± 0.5, FVC: −0.7 ± 1.0, FEV1/FVC: −2.6 ± 0.7) and by increased Rrs5 (median (IQR) z‐score) 2.7 (1.9 to 3.2) and decreased Xrs5: −4.1(−2.4 to −7.3). Lung compliance (K) was increased in 9 of 18 subjects and lung elastic recoil (B/A) reduced in 5 of 18 subjects. FEV1/FVC correlated negatively with K (rs = −0.60, P = 0.008) and Rrs5 correlated negatively with B/A (rs = −0.52, P = 0.026), independent of age. Xrs5 did not correlate with lung elasticity indices.Conclusion: Increased lung compliance and loss of elastic recoil relate to airflow obstruction in older non‐smoking asthmatic subjects, independent of ageing. Thus, structural lung tissue changes may contribute to persistent, steroid‐resistant airflow obstruction.Clinical trial registration: ACTRN126150000985583 at anzctr.org.au (UTN: U1111‐1156‐2795)
- Open Access
- 27 March 2019
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 28 (151) , 180122
Dismantling airway disease with the use of new pulmonary function indices
We are currently limited in our abilities to diagnose, monitor disease status and manage chronic airway disease like asthma and chronic obstructive pulmonary disease (COPD). Conventional lung function measures often poorly reflect patient symptoms or are insensitive to changes, particularly in the small airways where disease may originate or manifest. Novel pulmonary function tests are becoming available which help us better characterise and understand chronic airway disease, and their translation and adoption from the research arena would potentially enable individualised patient care.In this article, we aim to describe two emerging lung function tests yielding novel pulmonary function indices, the forced oscillation technique (FOT) and multiple breath nitrogen washout (MBNW). With a particular focus on asthma and COPD, this article demonstrates how chronic airway disease mechanisms have been dismantled with the use of the FOT and MBNW. We describe their ability to assess detailed pulmonary mechanics for diagnostic and management purposes including response to bronchodilation and other treatments, relationship with symptoms, evaluation of acute exacerbations and recovery, and telemonitoring. The current limitations of both tests, as well as open questions/directions for further research, are also discussed.
- 27 March 2019
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 28 (151) , 180122
Open AccessDismantling airway disease with the use of new pulmonary function indices
We are currently limited in our abilities to diagnose, monitor disease status and manage chronic airway disease like asthma and chronic obstructive pulmonary disease (COPD). Conventional lung function measures often poorly reflect patient symptoms or are insensitive to changes, particularly in the small airways where disease may originate or manifest. Novel pulmonary function tests are becoming available which help us better characterise and understand chronic airway disease, and their translation and adoption from the research arena would potentially enable individualised patient care.In this article, we aim to describe two emerging lung function tests yielding novel pulmonary function indices, the forced oscillation technique (FOT) and multiple breath nitrogen washout (MBNW). With a particular focus on asthma and COPD, this article demonstrates how chronic airway disease mechanisms have been dismantled with the use of the FOT and MBNW. We describe their ability to assess detailed pulmonary mechanics for diagnostic and management purposes including response to bronchodilation and other treatments, relationship with symptoms, evaluation of acute exacerbations and recovery, and telemonitoring. The current limitations of both tests, as well as open questions/directions for further research, are also discussed.
- 31 July 2017
- Published by Springer Nature in Journal of Clinical Monitoring and Computing
- Vol. 32 (3) , 509-512
Discrepancy between in vivo and in vitro comparisons of forced oscillation devices
The forced oscillation technique (FOT) is an emerging clinical lung function test, with commercial devices becoming increasingly available. However comparability across existing devices has not been established. We evaluated in vivo and in vitro measurements made using three commercial devices against a custom-built device (WIMR): Resmon Pro Diary (Restech srl, Italy), tremoFlo C-100 (Thorasys Medical Systems, Canada), Jaeger Masterscope CT IOS (CareFusion, Hoechberg, Germany). Respiratory system resistance Rrs and reactance Xrs at 5 Hz were examined in twelve healthy subjects (mean age 33 ± 11 years, 7 males), and in two test standards of known resistance and reactance. Subjects performed three measurements during tidal breathing on the four devices in random order. Total, inspiratory and expiratory Rrs and Xrs were calculated and compared using one-way repeated measures ANOVA and Bonferroni post-hoc tests. Rrs did not differ between devices, with <10% deviation from predicted, except for the IOS device. With Xrs, similar values were seen between the WIMR and Resmon devices and between the tremoFlo and IOS devices. No differences were observed using test standards; deviation from theoretical value was <2% for resistance and <5% for reactance. The WIMR, tremoFlo and Resmon Pro but not IOS devices measure similar Rrs, whereas there was more disparity across devices in the estimation of Xrs parameters. The discrepancy between in vivo and in vitro measurements suggest that FOT validation procedures need to take into account the breathing pattern, either using biological controls or a breathing model.
- 31 July 2017
- Published by Springer Nature in Journal of Clinical Monitoring and Computing
- Vol. 32 (3) , 509-512
Discrepancy between in vivo and in vitro comparisons of forced oscillation devices
The forced oscillation technique (FOT) is an emerging clinical lung function test, with commercial devices becoming increasingly available. However comparability across existing devices has not been established. We evaluated in vivo and in vitro measurements made using three commercial devices against a custom-built device (WIMR): Resmon Pro Diary (Restech srl, Italy), tremoFlo C-100 (Thorasys Medical Systems, Canada), Jaeger Masterscope CT IOS (CareFusion, Hoechberg, Germany). Respiratory system resistance Rrs and reactance Xrs at 5 Hz were examined in twelve healthy subjects (mean age 33 ± 11 years, 7 males), and in two test standards of known resistance and reactance. Subjects performed three measurements during tidal breathing on the four devices in random order. Total, inspiratory and expiratory Rrs and Xrs were calculated and compared using one-way repeated measures ANOVA and Bonferroni post-hoc tests. Rrs did not differ between devices, with <10% deviation from predicted, except for the IOS device. With Xrs, similar values were seen between the WIMR and Resmon devices and between the tremoFlo and IOS devices. No differences were observed using test standards; deviation from theoretical value was <2% for resistance and <5% for reactance. The WIMR, tremoFlo and Resmon Pro but not IOS devices measure similar Rrs, whereas there was more disparity across devices in the estimation of Xrs parameters. The discrepancy between in vivo and in vitro measurements suggest that FOT validation procedures need to take into account the breathing pattern, either using biological controls or a breathing model.